A date for your diary: the next course "Update on Pharmacoeconomics in the Irish Healthcare setting" will take place on 21st & 22nd March 2018 in Dublin Castle. Course programme and registration form now available. Course now full.
The NCPE does not recommend reimbursement of Teduglutide (Revestive®) for the treatment of patients aged 1 year and above with short bowel syndrome.
The NCPE are delighted to facilitate the delivery of the HTA module of the IPPOSI Pilot Patient Education Programme, commencing this Monday 22nd January. This module will provide students with a detailed knowledge of the principals of HTA, and has been adapted by the NCPE to provide particular insight into